Greetings from Precision Cancer Medicine! We are pleased to share with you the brief report of the journal. PCM has made some significant progress since its birth in April 2018, especially in terms of building up of the internationalized editorial board and organizing focused issues. We would like to express our heartfelt appreciation to all the editorial board members, authors, reviewers and readers for your precious support and contributions at the very beginning of the journal. We would look forward to the joint efforts with colleagues in the field of cancer research in pursuit of precise diagnosis and treatment of cancers and personalized care for patients.
Xiaomao Guo, MD
Editor-in-Chief, Precision Cancer Medicine
Zhimin Shao, MD
Executive Editor-in-Chief, Precision Cancer Medicine